Woodside, D. B., Garfinkel, P. E., Lin, E., Goering, P., Kaplan, A. S., Goldbloom, D. S., & Kennedy, S. H. (2001). Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community. American Journal of Psychiatry, 158, 570–574. 

World Health Organization. (1990). International classification of diseases and related health problems (10th revision). Geneva: Author.

Yager, J., Landsverk, J., & Edelstein, C. K. (1987). A 20-month follow-up study of 628 women with eating disorders, I: course and severity. American Journal of Psychiatry, 144, 1172–1177.

Yager, J., Landsverk, J., Edelstein, C. K., & Jarvik, M. (1988). A 20-month follow-up study of 628 women with eating disorders: II. Course of associated symptoms and related clinical features. International Journal of Eating Disorders, 7, 503–513.

Yannakoulia, M., Sitara, M., & Matalas, A. L. (2002). Reported eating behavior and attitudes improvement after a nutrition intervention program in a group of young female dancers. International Journal of Sports Nutrition Exercise and Metabolism, 12, 24–32.

Yanovski, S. Z. (2002). Binge eating in obese persons. In C. G. Fairburn & K. D. Brownell (Eds.), Eating disorders and obesity: A comprehensive handbook (pp. 403–407). New York: Guilford Press.

Youth Risk Behavior Surveillance System. (2003). Youth Risk Behavior Survey [Web site]. Retrieved May 19, 2003, from http://www.cdc.gov/nccdphp/dash/yrbs/about yrbss.htm

Zhu, A. J., & Walsh, B. T. (2002). Pharmacologic treatment of eating disorders. Canadian Journal of Psychiatry, 47, 227–234.

Abraham, H. D., Aldridge, A. M., & Gogia, P. (1996). The psychopharmacology of hallucinogens. Neuropsychopharmacology, 14, 285–298. 

Abraham, H., McCann, U., & Ricaurte, G. (2002). Psychedelic drugs. In K. Davis, D. Charney, J. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology, the fifth generation of progress, (pp. 1545–1556) New York: Lippincott Williams & Wilkins.

Abreu-Villaca, Y., Seidler, F. J., Qiao, D., Tate, C. A., Cousins, M. M., Thillai, I., et al. (2003). Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: Critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology, 28(11): 1935–1949.

Addolorato, G., Caputo, F., Capristo, E., Colombo, G., Gessa, G. L., & Gasbarrini, G. (2000). Ability of baclofen in reducing alcohol craving and intake: II—Preliminary clinical evidence. Alcoholism, Clinical and Experimental Research, 24, 67–71. 

Adelman, H. S., & Taylor, L. (2003). On sustainability of project innovations as systemic change. Journal of Educational and Psychological Consultation, 14(1): 1–25. 

Aghajanian, G. K., & Marek, G. J. (1999). Serotonin and hallucinogens. Neuropsychopharmacology, 21(2 Suppl), 16S–23S.

Ahmed, S. H., & Koob, G. F. (1998). Transition from moderate to excessive drug intake: Change in hedonic set point. Science, 282, 298–300. 

Aigner, T. G., & Balster, R. L. (1978). Choice behavior in rhesus monkeys: Cocaine versus food. Science, 201, 534–535.

Akhondzadeh, S., Ahmadi-Abhari, S. A., Assadi, S. M., Shabestari, O. L., Kashani, A. R., & Farzanehgan, Z. M. (2000). Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal. Journal of Clinical Pharmacy and Therapeutics, 25, 347–353. 

Alper, K. R. (2001). Ibogaine: A review. The Alkaloids, Chemistry & Biology, 56, 1–38.

Altman, D. G. (1995). Sustaining interventions in community systems: On the relationship between researchers and communities. Health Psychology, 14, 526–536. 

Alvarado, A., Kendell, K., Beesley, S., & Lee-Cavaness, C. (2000). Strengthening American families: Model family programs for substance abuse and delinquency prevention. Salt Lake City, UT: University of Utah, Department of Health Promotion and Education.

American Legacy Foundation. (2002). Media tracking survey (unpublished data).

American Psychiatric Association (APA). (1994). Diagnostic and statistical manual of mental disorders (4th ed.) (DSM IV). Washington, DC: Author.

Anderson, C. E., & Loomis, G. A. (2003). Recognition and prevention of inhalant abuse. American Family Physician, 68, 869–874.

Anonymous. (2003). Inhalant abuse treatment and prevention. Public Health Reports, 118, 276.

Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the